Research into serious lung diseases at Imperial College London is the most highly cited in the world, according to an analysis by the information provider Thomson Reuters.
This covered published academic research in chronic obstructive pulmonary disease (COPD), a group of progressive inflammatory conditions that includes emphysema and chronic obstructive bronchitis.
The analysis covered papers on COPD published over a ten-year period by nearly 10,000 institutions across 113 countries. The results show that Imperial achieved more citations for COPD than any other institution. In addition, Peter Barnes, the Head of Airway Disease at Imperial's National Heart and Lung Institute, achieved more citations for his work on COPD than any other researcher in the world.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.